EGLT Insider Trading Activity and SEC Form 4 Filings
EGLT insider trading summary
No open-market insider purchases or sales of Egalet Corp (EGLT) have been reported on SEC Form 4 in the past 12 months.
Latest EGLT insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jan 2, 2018 | Patrick M Shea | Chief Commercial Officer | Sell | $910 (910 @ $1.00) |
| Oct 2, 2017 | Patrick M Shea | Chief Commercial Officer | Sell | $1K (910 @ $1.30) |
| Oct 2, 2017 | Mark Strobeck | Chief Operating Officer | Sell | $11K (8,700 @ $1.29) |
| Jul 3, 2017 | Patrick M Shea | Chief Commercial Officer | Sell | $2K (910 @ $2.35) |
| Jul 3, 2017 | Paul Varki | SVP, GC & Chief Compliance Off | Sell | $2K (806 @ $2.35) |
| Jul 3, 2017 | Stan Musial | Chief Financial Officer | Sell | $8K (3,480 @ $2.36) |
| Jun 30, 2017 | Mark Strobeck | Chief Operating Officer | Sell | $21K (8,700 @ $2.39) |
| Apr 3, 2017 | Paul Varki | SVP, GC & Chief Compliance Off | Sell | $4K (806 @ $5.05) |
| Apr 3, 2017 | Stan Musial | Chief Financial Officer | Sell | $43K (8,613 @ $5.04) |
| Mar 31, 2017 | Jeffrey M. Dayno | Chief Medical Officer | Sell | $3K (536 @ $5.16) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.